- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 18, 2026 | 52.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 50.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 48.61M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$56.22K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$18.33K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $0 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $0 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$1.66M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$1.68M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.22M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.13M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.14M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.05M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $59K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $53.56K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $75K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $54.56K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $37.29K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $25.7K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$139.66K |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.89K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$119.55K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $22.73K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$11.98K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $125.35K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.26K |
| Revenue | Q1 2026 · Mar 31, 2025 | $164.66K |